268 related articles for article (PubMed ID: 11344192)
1. In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus.
Frénais R; Nazih H; Ouguerram K; Maugeais C; Zaïr Y; Bard JM; Charbonnel B; Magot T; Krempf M
J Clin Endocrinol Metab; 2001 May; 86(5):1962-7. PubMed ID: 11344192
[TBL] [Abstract][Full Text] [Related]
2. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
Pérez-Méndez O; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
Clin Chim Acta; 2006 Jun; 368(1-2):149-54. PubMed ID: 16487502
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes.
Bach-Ngohou K; Ouguerram K; Nazih H; Maugère P; Ripolles-Piquer B; Zaïr Y; Frénais R; Krempf M; Bard JM
Int J Obes Relat Metab Disord; 2002 Nov; 26(11):1451-8. PubMed ID: 12439646
[TBL] [Abstract][Full Text] [Related]
4. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.
Goldberg IJ; Blaner WS; Vanni TM; Moukides M; Ramakrishnan R
J Clin Invest; 1990 Aug; 86(2):463-73. PubMed ID: 2117022
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
Saku K; Gartside PS; Hynd BA; Mendoza SG; Kashyap ML
Metabolism; 1985 Aug; 34(8):754-64. PubMed ID: 3927110
[TBL] [Abstract][Full Text] [Related]
6. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins.
Tan KC; Shiu SW; Pang RW; Kung AW
Clin Endocrinol (Oxf); 1998 Feb; 48(2):187-94. PubMed ID: 9579231
[TBL] [Abstract][Full Text] [Related]
7. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
de Vries R; Borggreve SE; Dullaart RP
Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
[TBL] [Abstract][Full Text] [Related]
8. Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity.
Magill P; Rao SN; Miller NE; Nicoll A; Brunzell J; St Hilaire J; Lewis B
Eur J Clin Invest; 1982 Apr; 12(2):113-20. PubMed ID: 6807682
[TBL] [Abstract][Full Text] [Related]
9. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.
Brinton EA; Eisenberg S; Breslow JL
J Clin Invest; 1991 Feb; 87(2):536-44. PubMed ID: 1899429
[TBL] [Abstract][Full Text] [Related]
10. In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance.
Pietzsch J; Julius U; Nitzsche S; Hanefeld M
Diabetes; 1998 Dec; 47(12):1928-34. PubMed ID: 9836526
[TBL] [Abstract][Full Text] [Related]
11. Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus.
Frénais R; Ouguerram K; Maugeais C; Mahot P; Charbonnel B; Magot T; Krempf M
Atherosclerosis; 2001 Jul; 157(1):131-5. PubMed ID: 11427212
[TBL] [Abstract][Full Text] [Related]
12. Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.
De Vries R; Wolffenbuttel BH; Sluiter WJ; van Tol A; Dullaart RP
Clin Lab; 2005; 51(7-8):403-9. PubMed ID: 16122151
[TBL] [Abstract][Full Text] [Related]
13. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin is an important determinant of apoA-I catabolism.
Vergès B; Petit JM; Duvillard L; Dautin G; Florentin E; Galland F; Gambert P
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1364-9. PubMed ID: 16574896
[TBL] [Abstract][Full Text] [Related]
15. Increased cholesteryl ester transfer protein activity in impaired glucose tolerance: relationship to high density lipoprotein metabolism.
Pietzsch J; Fuecker K
Croat Med J; 2003 Apr; 44(2):171-7. PubMed ID: 12698508
[TBL] [Abstract][Full Text] [Related]
16. Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity.
Kahri J; Vuorinen-Markkola H; Tilly-Kiesi M; Lahdenperä S; Taskinen MR
Atherosclerosis; 1993 Aug; 102(1):79-89. PubMed ID: 8257455
[TBL] [Abstract][Full Text] [Related]
17. Effects of atorvastatin on high-density lipoprotein apolipoprotein A-I metabolism in dogs.
Briand F; Magot T; Krempf M; Nguyen P; Ouguerram K
Eur J Clin Invest; 2006 Apr; 36(4):224-30. PubMed ID: 16620283
[TBL] [Abstract][Full Text] [Related]
18. High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study.
Frénais R; Ouguerram K; Maugeais C; Mahot P; Maugère P; Krempf M; Magot T
Diabetologia; 1997 May; 40(5):578-83. PubMed ID: 9165227
[TBL] [Abstract][Full Text] [Related]
19. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
Breier C
Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
[TBL] [Abstract][Full Text] [Related]
20. High-density lipoprotein apolipoprotein A-I kinetics in obese insulin resistant patients. An in vivo stable isotope study.
Pont F; Duvillard L; Florentin E; Gambert P; Vergès B
Int J Obes Relat Metab Disord; 2002 Sep; 26(9):1151-8. PubMed ID: 12187390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
